ObsEva SA: ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - September 30, 2021 - ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing

Related Keywords

Geneva ,Genè ,Switzerland ,Rome ,Lazio ,Italy ,Swiss ,Shauna Dillon ,Luigi Marro ,Brian Ocallaghan ,Joyce Allaire ,Master Of Business Administration ,Exchange Commission ,Voisin Life Sciences Consulting ,Strategy Development ,Economical Statistic Sciences ,Swiss Exchange ,Chief Transformation Officer ,Executive Committee ,Commercial Operational Readiness ,Briano Callaghan ,Chief Executive Officer ,Chief Financial Officer ,Finox Biotech ,Chief Operating Officer ,Merck Serono ,Senior Director Strategy Development ,Business Administration ,Luiss Management ,Nasdaq Global Select Market ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Obseva ,Nnounces ,Appointment ,Luigi ,Farro ,Chief ,Transformation ,Officer ,